A dominant negative mutation of transforming growth factor-β receptor type II gene in microsatellite stable oesophageal carcinoma

British Journal of Cancer

Volumn 82, Issue 9, 2000, Pages 1557-1560

  Tanaka, Shinji ^a   Mori, Masaki ^a   Mafune, Ken ichi ^b   Ohno, Shinji ^a   Sugimachi, Keizo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Kyushu University ^*

Author keywords

Microsatellite; Oesophageal carcinoma; Smad2; Smad4; TGF RII

Indexed keywords

SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; HUMAN; HUMAN CELL; MICROSATELLITE INSTABILITY; MISSENSE MUTATION; PRIORITY JOURNAL; PROTEIN TRANSPORT; RECEPTOR GENE; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; BASE SEQUENCE; DNA PRIMERS; ESOPHAGEAL NEOPLASMS; GENES, DOMINANT; HUMANS; MICROSATELLITE REPEATS; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;

EID: 0034077778     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. De M, Yan W, de Jonge RR, Garrigue-Antar L, Vellucci VF and Reiss M (1998) Functional characterization of transforming growth factor β type II receptor mutants in human cancer. Cancer Res 58: 1986-1992
2. Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui LC, Bapat B, Gallinger S, Andrulis IL, Thomsen GH, Wrana JL and Attisano L (1996) MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86: 543-552
3. Fishel R (1998) Mismatch repair molecular switches and signal transduction. Genes Dev 12: 2096-2101
4. Garrigue-Antar L, Munoz-Antonia T, Antonia SJ, Gesmonde J, Vellucci VF and Reiss M (1995) Missense mutations of the transforming growth factor β type II receptor in human head and neck squamous carcinoma cells. Cancer Res 55: 3982-3987
5. Grady WM, Myeroff LL, Swinler SE, Rajput A, Thiagalingam S, Lutterbaugh JD, Neumann A, Brattain MG, Chang J, Kim SJ, Kinzler KW, Vogelstein B, Willson JK and Markowitz S (1999) Mutational inactivation of transforming growth factor β receptor type II in microsatellite stable colon cancers. Cancer Res 59: 320-324
6. Hata A, Shi Y and Massague J (1998) TGF-β signaling and cancer: structural and functional consequences of mutations in Smads. Mol Med Today 4: 257-262
7. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH and Kern SE (1996) DPC4 a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271: 350-353
8. Kretzschmar M and Massague J (1998) SMADs: mediators and regulators of TGF-β signaling. Curr Opin Genet Dev 8: 103-111
9. Lengauer C, Kinzler KW and Vogelstein B (1998) Genetic instabilities in human cancers. Nature 396: 643-649
10. Markowitz S, Wang J, Myeroff L, Parsons R, Sun LZ, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, et al (1995) Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268: 1336-1338
11. Massague J (1998) TGF-β signal transduction. Annu Rev Biochem 67: 753-791
12. Nakashima H, Mori M, Mimori K, Inoue H, Shibuta K, Baba K, Mafune K and Akiyoshi T (1995) Microsatellite instability in Japanese esophageal carcinoma. Int J Cancer 64: 286-289
13. Sugimachi K, Watanabe M, Sadanaga N, Ikebe M, Kitamura K, Mori M and Kuwano H (1994) Recent advances in the diagnosis and surgical treatment of patients with carcinoma of the esophagus. J Am Coll Surg 178: 363-368
14. Tanaka S and Wands JR (1996) Insulin receptor substrate 1 overexpression in human hepatocellular carcinoma cells prevents transforming growth factor β-induced apoptosis. Cancer Res 56: 3391-3394
15. Tanaka S, Toh Y, Adachi E, Matsumata T, Mori R and Sugimachi K (1993) Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation. Cancer Res 53: 2884-2887
16. Tanaka S, Akiyoshi T, Mori M, Wands JR and Sugimachi K (1998) A novel frizzled gene identified in human esophageal carcinoma that mediates APC/β-catenin signals. Proc Natl Acad Sci USA 95: 10164-10169
17. Wang J, Sun LZ, Myeroff L, Wang XF, Gentry LE, Yang J, Liang J, Zborowska E, Markowitz S, Willson JKV and Brattain MG (1995) Demonstration that mutation of the type II transforming growth factor receptor β inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J Biol Chem 270: 22044-22049
18. Wrana JL, Attisano L, Wieser R, Ventura F and Massague J (1994) Mechanism of activation of the TGF-β receptor. Nature 370: 341-347